Literature DB >> 16912943

Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid.

F Strle1, E Ruzić-Sabljić, J Cimperman, S Lotric-Furlan, V Maraspin.   

Abstract

BACKGROUND: The most common cause of Lyme neuroborreliosis in Europe is Borrelia garinii, followed by Borrelia afzelii. However, no series describing patients with culture-confirmed cases of Lyme neuroborreliosis have been published, and no comparison of findings for patients with B. garinii and B. afzelii isolated from cerebrospinal fluid (CSF) has been reported.
METHODS: All adult patients identified at a single medical center during a 10-year period who had borreliae isolated from CSF and typed as B. garinii or B. afzelii (using large DNA fragment patterns obtained with the MluI restriction endonuclease and separated with pulsed-field gel electrophoresis) were included.
RESULTS: A comparison of 23 patients who had B. garinii isolated from CSF with 10 patients who had B. afzelii isolated from CSF revealed that a reliable clinical diagnosis of Lyme neuroborreliosis (before obtaining a CSF culture and intrathecal borrelial antibody production result) was established more frequently in the B. garinii group than in the B. afzelii group (19 of 23 patients vs. 1 of 10 patients). Patients in the B. garinii group reported radicular pains and expressed meningeal signs more often, but reported dizziness less often (occurrences of several other symptoms and/or signs were comparable). Lymphocytic pleocytosis, as well as several other CSF abnormalities, were frequent among patients with B. garinii isolated from CSF but were rare among patients in the B. afzelii group.
CONCLUSIONS: Patients with B. garinii isolated from their CSF have a distinct clinical presentation, compared with patients with B. afzelii. B. garinii causes what, in Europe, is appreciated as typical early Lyme neuroborreliosis (Bannwarth syndrome), whereas the clinical features associated with B. afzelii are much less specific and more difficult to diagnose.

Entities:  

Mesh:

Year:  2006        PMID: 16912943     DOI: 10.1086/506936

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].

Authors:  T A Rupprecht; C Lechner; H Tumani; V Fingerle
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Toward a better understanding of European lyme neuroborreliosis.

Authors:  Gary P Wormser; John J Halperin
Journal:  Clin Infect Dis       Date:  2013-05-10       Impact factor: 9.079

Review 4.  Evolutionary aspects of emerging Lyme disease in Canada.

Authors:  N H Ogden; E J Feil; P A Leighton; L R Lindsay; G Margos; S Mechai; P Michel; T J Moriarty
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

Review 5.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

6.  Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa.

Authors:  J Molepo; A Pillay; B Weber; S A Morse; A A Hoosen
Journal:  Sex Transm Infect       Date:  2007-01-23       Impact factor: 3.519

7.  Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.

Authors:  Bjørn Barstad; Hanne Quarsten; Dag Tveitnes; Sølvi Noraas; Ingvild S Ask; Maryam Saeed; Franziskus Bosse; Grete Vigemyr; Ilka Huber; Knut Øymar
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

8.  Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

Authors:  Jennifer A Caine; Yi-Pin Lin; Julie R Kessler; Hiromi Sato; John M Leong; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2017-09-26       Impact factor: 3.715

9.  Geographic Range of Lyme Borreliosis in Mongolia.

Authors:  Michael E von Fricken; Lkhunrev Rolomjav; Madeline Illar; Doniddemberel Altantogtokh; Kathryn M Hogan; Baasandagva Uyanga; Dalantai Ganbold; Nyamdorj Tsogbadrakh
Journal:  Vector Borne Zoonotic Dis       Date:  2019-03-05       Impact factor: 2.133

10.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Authors:  Øystein Brorson; Sverre-Henning Brorson; John Scythes; James MacAllister; Andrew Wier; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.